研究業績

  1. ホーム
  2. 業績
  3. 研究業績
  4. 2008年

2008年研究業績

英文原著

  1. Kim SW, Matsuo K, Fukuda T, Hara M, Matsue K, Taniguchi S, Eto T, Tanimoto M, Wake A, Hatanaka K, Nakao S, Ishida Y, Harada M, Utsunomiya A, Imamura M, Kanda Y, Sunami K, Kawano F, Takaue Y, Teshima T: Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. Int J Hematol. 2008 Oct; 88(3): 324-330
  2. Shigematsu A, Adachi Y, Matsubara J, Mukaide H, Koike-Kiriyama N, Minamino K, Shi M, Yanai S, Imamura M, Taketani S, Ikehara S: Analyses of expression of cytoglobin by immunohistochemical studies in human tissues. Hemoglobin. 2008 32(3): 287-296
  3. Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M: Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2008 May; 14(5): 568-575
  4. Mukaide H, Adachi Y, Taketani S, Iwasaki M, Koike-Kiriyama N, Shigematsu A, Shi M, Yanai S, Yoshioka K, Kamiyama Y, Ikehara S: FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma. Cancer Invest. 2008 May; 26(4): 385-390
  5. Suzuki Y, Adachi Y, Zhang Y, Minamino K, Iwasaki M, Mukaide H, Shi M, Nakano K, Koike Y, Wang J, Koike-Kiriyama N, Shigematsu A, Yanai S, Ikehara S: Administration of granulocyte colony-stimulating factor to recipients followed by intra-bone marrow-bone marrow transplantation accelerates acceptance of allogeneic bone marrow cells in mice. Immunobiology. 2008 213(5): 427-435
  6. Koike-Kiriyama N, Adachi Y, Iwasaki M, Amou Y, Shigematsu A, Koike Y, Minamino K, Mukaide H, Shi M, Yanai S, Matsumura M, Ikehara S: High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells. Clin Exp Immunol. 2008 Nov; 154(2): 285-293
  7. Shi M, Adachi Y, Shigematsu A, Koike-Kiriyama N, Feng W, Yanai S, Yunze C, Lian ZX, Li J, Ikehara S: Intra-bone marrow injection of donor bone marrow cells suspended in collagen gel retains injected cells in bone marrow, resulting in rapid hemopoietic recovery in mice. Stem Cells. 2008 Sep; 26(9): 2211-2216
  8. Sugita J, Tanaka J, Kurosawa M, Fukuhara T, Hashino S, Torimoto E, Koizumi K, Masauji N, Nishimura S, Koda K, Imamura M, Kasai M; Hokkaido Hematology Study Group: Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group. Eur J Haematol. 2008 Feb; 80(2): 160-163
  9. Sugita J, Iwao N, Tanaka J, Kato N, Shiratori S, Wakasa K, Shigematsu A, Toubai T, Takahata M, Kondo T, Asaka M, Imamura M: T cell receptor excision circle levels in CD94-expressing CD8 T cells during graft-versus-host disease. Leuk Lymphoma. 2008 Jul; 49(7): 1306-1310
  10. Sugita J, Tanaka J, Hashimoto A, Shiratori S, Yasumoto A, Wakasa K, Kikuchi M, Shigematsu A, Miura Y, Tsutsumi Y, Kondo T, Asaka M, Imamura M: Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation. Ann Hematol. 2008 Dec; 87(12): 1003-1008
  11. Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N, Matsushima K: Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood. 2008 Jun 15; 111(12): 5457-5466
  12. Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, Hashino S, Morita R, Takahata M, Onozawa M, Kahata K, Kondo T, Ota S, Wakasa K, Sugita J, Koike T, Asaka M, Kasai M, Imamura M: A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant. 2008 Jul; 14(7): 817-823
  13. Kaji M, Tanaka J, Sugita J, Kato N, Ibata M, Shono Y, Ohta S, Kondo T, Asaka M, Imamura M: Ciprofloxacin inhibits lipopolysaccharide-induced toll-like receptor-4 and 8 expression on human monocytes derived from adult and cord blood. Ann Hematol. 2008 Mar; 87(3): 229-231
  14. Hashino S, Morioka M, Irie T, Shiroshita N, Kawamura T, Suzuki S, Iwasaki H, Umehara S, Kakinoki Y, Kurosawa M, Kahata K, Izumiyama K, Kobayashi H, Onozawa M, Takahata M, Fujisawa F, Kondo T, Asaka M: Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma. Int J Lab Hematol. 2008 Aug: 30(4): 292-299
  15. Hashino S, Morita L, Takahata M, Onozawa M, Nakagawa M, Kawamura T, Fujisawa F, Kahata K, Izumiyama K, Yonezumi M, Chiba K, Kondo T, Asaka M: Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation. Int J Hematol. 2008 Jan; 87(1): 91-97
  16. Kondo T, Mori A, Darmanin S, Hashino S, Tanaka J, Asaka M: The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive Acute Promyelocytic Leukemia. Haematologica. 2008 Sep; 93(9): 1414-1416
  17. Onozawa M, Hashino S, Darmanin S, Okada K, Morita R, Shigematsu A, Kahata K, Kondo T, Tanaka J, Imamura M, Asaka M: HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant. 2008 Nov; 14(11): 1226-1230
  18. Takahata. M, Bohgaki. M, Tsukiyama. T, Kondo. T, Asaka. M, Hatakeyama. S: Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system. Mol Immunol. 2008 Apr; 45(7): 2045-2054
  19. Yoda A, Toyoshima K, Watanabe Y, Onishi N, Hazaka Y, Tsukuda Y, Tsukada J, Kondo T, Tanaka Y and Minami Y: Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. J Biol Chem. 2008 Jul 4; 283(27): 18969-18979

英文症例報告

  1. Toubai T, Hirate D, Shono Y, Ota S, Ibata M, Mashiko S, Sugita J, Shigematsu A, Miura Y, Kato N, Umehara S, Kahata K, Tsutsumi Y, Iwao N, Toyoshima N, Tanaka J, Asaka M, Imamura M: Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma. Int J Lab Hematol. 2008 Feb; 30(1): 75-81
  2. Shiratori S, Tsutsumi Y, Kawamura T, Kudo K, Shimoyama N, Masauzi N, Tanaka J, Asaka M, Imamura M: HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level: a retrospective analysis in one institution. Int J Hematol. 2008 Apr; 87(3): 298-302
  3. Hashino. S, Kobayashi. S, Takahata. M, Onozawa. M, Nakagawa. M, Kawamura. T, Fujisawa. F, Izumiyama. K, Kahata. K, Kondo. T, Asaka M: Graft-versus-tumor effect after reduced-intensity allogeneic hematopoirtic stem cell transplantation in a patient with advanced colon cancer. Int J Clin Oncol. 2008 Apr; 13(2): 176-180
  4. Kahata K, Hashino S, Takahata M, Fujisawa F, Kondo T, Kobayashi S, Fujita Y, Shimizu H, Imamura M, Asaka M: Durable remission of Sezary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning. Acta Haematol. 2008 120(1): 14-18
  5. Morita R, Hashino S, Shirai S, Fujita N, Onozawa M, Kahata K, Kondo T, Imamura M, Asaka M: Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol. 2008 Sep; 88(2): 248-250
  6. Nishio M, Endo T, Nakao S, Sato N, Koike T.: Reversible cardiomyopathy due to secondary hemochromatosis with multitransfusions for severe aplastic anemia after successful non-myeloablative stem cell transplantation. Int J Cardiol. 2008 Jul 21; 127(3): 400-401
  7. Goto H, Nishio M, Kumano K, Fujimoto K, Yamaguchi K, Koike T.: Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation. Bone Marrow Transplant. 2008 Nov; 42(9): 627-629

和文総説

  1. 今村雅寛:移植後の免疫回復の評価 みんなに役立つ造血幹細胞移植の基礎と臨床;136-141,2008.
  2. 今村雅寛:高齢者MDS(骨髄異形成症候群)の特徴と治療 血液フロンティア 18;419-426,2008.
  3. 今村雅寛:同種造血幹細胞移植後の超急性移植片対宿主病 血液フロンティア 18;1819-1823,2008.
  4. 田中淳司:GVHDとGVL制御におけるNK受容体発現細胞の役割 臨床血液 49;598-606,2008.
  5. 橋野 聡:臨床編移植合併症9.心合併症 みんなに役立つ造血幹細胞移植の基礎と臨床 下巻;72-76,2008.

和文症例報告

  1. 白鳥聡一,近藤 健,久保田佳奈子,若狭健太郎,井端 淳,庄野雄介,高畑むつみ,重松明男,加藤菜穂子,太田秀一,田中淳司,松野吉宏,浅香正博,今村雅寛:Rituximab投与によりCD20の陰性化が認められたCD20陽性・Cyclin D1陽性多発性骨髄腫.臨床血液 49;1536-1540,2008.
  2. 守田玲菜,橋野 聡,高橋正二郎,金森弘恵,小野澤真弘,加畑 馨,近藤 健,今村雅寛,浅香正博:顆粒球輸血の併用により同種造血幹細胞移植を施行し得た肺炎合併MDS-RAEB-2 臨床血液 49;89-93,2008.
  3. 守田玲菜,橋野 聡,小野澤真弘,加畑 馨,近藤 健,今村雅寛,浅香正博:サイトメガロウイルスによる虚血性腸炎を合併したAIDS症例 日本エイズ学会誌 10;200-205,2008.

和文原著

  1. 重松明男,杉田純一,山本 聡,小野澤真宏,遠藤知之,加畑 馨,白鳥聡一,若狭健太郎,高畑むつみ,近藤 健,田中淳司,西尾充史,橋野 聡,小池隆夫,浅香正博,今村雅寛:骨髄非破壊的前処置と骨髄破壊的前処置による同種骨髄移植後感染症の比較.無菌生物 38;27-32,2008.
  2. 橋野 聡:貧血が起こる.「胃がん・大腸がんを薬で抑えましょう」と言われた時 ヴァン・メディカル(株)小松嘉人編集 93;2008.
  3. 橋野 聡:出血が起こりやすい.「胃がん・大腸がんを薬で抑えましょう」と言われた時 ヴァン・メディカル(株)小松嘉人編集 94;2008.
  4. 橋野 聡:白血球が少なくなる.「胃がん・大腸がんを薬で抑えましょう」と言われた時 ヴァン・メディカル(株)小松嘉人編集 95-96;2008.
  5. 橋野 聡:血小板が少なくなる.「胃がん・大腸がんを薬で抑えましょう」と言われた時 ヴァン・メディカル(株)小松嘉人編集 97;2008.
  6. 熊野弘毅:ヒトCD34陽性細胞におけるDOCK180の発現に関する検討、北海道医学雑誌、83: 41-46, 2008